DE69910706D1 - Medikament zur Behandlung von Glaukoma und ischämischer Retinopathie - Google Patents

Medikament zur Behandlung von Glaukoma und ischämischer Retinopathie

Info

Publication number
DE69910706D1
DE69910706D1 DE69910706T DE69910706T DE69910706D1 DE 69910706 D1 DE69910706 D1 DE 69910706D1 DE 69910706 T DE69910706 T DE 69910706T DE 69910706 T DE69910706 T DE 69910706T DE 69910706 D1 DE69910706 D1 DE 69910706D1
Authority
DE
Germany
Prior art keywords
ischemic retinopathy
drug used
treat glaucoma
mammal
retinopathy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69910706T
Other languages
English (en)
Other versions
DE69910706T2 (de
Inventor
Harry Ralph Howard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Publication of DE69910706D1 publication Critical patent/DE69910706D1/de
Application granted granted Critical
Publication of DE69910706T2 publication Critical patent/DE69910706T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Eye Examination Apparatus (AREA)
  • Surgical Instruments (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DE69910706T 1998-05-26 1999-05-05 Medikament zur Behandlung von Glaukoma und ischämischer Retinopathie Expired - Fee Related DE69910706T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8674598P 1998-05-26 1998-05-26
US86745P 1998-05-26

Publications (2)

Publication Number Publication Date
DE69910706D1 true DE69910706D1 (de) 2003-10-02
DE69910706T2 DE69910706T2 (de) 2004-07-08

Family

ID=22200630

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69910706T Expired - Fee Related DE69910706T2 (de) 1998-05-26 1999-05-05 Medikament zur Behandlung von Glaukoma und ischämischer Retinopathie

Country Status (16)

Country Link
EP (1) EP0985414B1 (de)
JP (1) JP2000026297A (de)
KR (2) KR100469188B1 (de)
AT (1) ATE247963T1 (de)
AU (1) AU762037B2 (de)
CA (1) CA2272665C (de)
DE (1) DE69910706T2 (de)
DK (1) DK0985414T3 (de)
ES (1) ES2204067T3 (de)
HU (1) HUP9901728A3 (de)
IL (1) IL130052A0 (de)
MY (1) MY133222A (de)
NZ (2) NZ508246A (de)
PT (1) PT985414E (de)
TW (1) TW581678B (de)
ZA (1) ZA993528B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2402403A1 (en) * 2000-03-17 2001-09-27 Alcon, Inc. 6-hydroxy-indazole derivatives for treating glaucoma
US6956036B1 (en) 2000-03-17 2005-10-18 Alcon, Inc. 6-hydroxy-indazole derivatives for treating glaucoma
EP1286672B1 (de) * 2000-06-02 2006-10-25 Pfizer Products Inc. S-methyl-dihydro-ziprasidon zur Behandlung von Augenerkrankungen.
WO2003007956A1 (en) 2001-07-20 2003-01-30 Psychogenics, Inc. Treatment for attention-deficit hyperactivity disorder

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2021262A1 (de) * 1970-04-30 1971-11-11 Cassella Farbwerke Mainkur Ag Piperazinderivate
US4130646A (en) * 1975-07-25 1978-12-19 E. R. Squibb & Sons, Inc. 1,2,3,4-Tetrahydro-2-((4-(phenyl)-1-piperazinyl)methyl)-1-naphthalenols and derivatives and analogs thereof
NZ196284A (en) * 1980-02-29 1983-12-16 Kefalas As 1-piperazino-3-phenylindane derivatives:pharmaceutical compositions
EP0233728A1 (de) * 1986-02-11 1987-08-26 Takeda Chemical Industries, Ltd. 1,4-Benzoxazin-Derivate, ihre Herstellung und Verwendung
US4831031A (en) * 1988-01-22 1989-05-16 Pfizer Inc. Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
US5350747A (en) * 1989-07-07 1994-09-27 Pfizer Inc Heteroaryl piperazine antipsychotic agents
ZA9010081B (en) * 1989-12-20 1991-10-30 Merrell Dow Pharma Method for the treatment of glaucoma
CA2036307C (en) * 1990-03-08 2002-07-09 Susan Jean Ward 3-arylcarbonyl-1-aminoalkyl-1h-indole-containing antiglaucoma compositions and method
US6110918A (en) * 1996-05-07 2000-08-29 Pfizer Inc Mesylate trihydrate salt of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihy dro-2(1H)-indol-2-one (=ziprasidone), its preparation and its use as dopamine D2 antagonist

Also Published As

Publication number Publication date
NZ508246A (en) 2004-12-24
JP2000026297A (ja) 2000-01-25
IL130052A0 (en) 2000-02-29
ZA993528B (en) 2000-11-27
ATE247963T1 (de) 2003-09-15
EP0985414A2 (de) 2000-03-15
AU762037B2 (en) 2003-06-19
AU3124299A (en) 1999-12-02
TW581678B (en) 2004-04-01
NZ335952A (en) 2001-01-26
CA2272665A1 (en) 1999-11-26
HUP9901728A3 (en) 2001-01-29
MY133222A (en) 2007-10-31
DE69910706T2 (de) 2004-07-08
KR20030086544A (ko) 2003-11-10
KR100469188B1 (ko) 2005-01-31
HUP9901728A2 (hu) 2000-12-28
EP0985414A3 (de) 2000-04-05
CA2272665C (en) 2003-08-05
DK0985414T3 (da) 2003-12-29
PT985414E (pt) 2004-01-30
KR19990088520A (ko) 1999-12-27
EP0985414B1 (de) 2003-08-27
ES2204067T3 (es) 2004-04-16

Similar Documents

Publication Publication Date Title
DE60316779D1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
NO20093464L (no) Nye medikamentblandinger basert pa anti-cholinergisk effektive forbindelser og beta-mimetika
OA09334A (fr) "Dérivés d'acides aminés".
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
HU9600834D0 (en) Quinazoline derivatives
MY119375A (en) Treatment of tinnitus using neuroprotective agents
PT992509E (pt) Novos derivados macrolidos
ATE268337T1 (de) C11-carbamate von antibakteriellen makroliden
DE69413118T2 (de) Benzolsulfonamid-Derivate zur Behandlung der Blaseninstabilität
YU224790A (sh) Aminokarbonil karbamati, sorodni fizostigminu/in postopek za njihovo pripravo in njihova uporaba kot zdravila
ATE366107T1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
ATE161725T1 (de) Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina
DE60026883D1 (de) Methoden und zusammensetzungen zur behandlung von schmerzen
DE69910706D1 (de) Medikament zur Behandlung von Glaukoma und ischämischer Retinopathie
NO971743L (no) Farmasöytisk sammensetning for profylakse og behandling av type I allergiske sykdommer
ATE359995T1 (de) Amin-1,2- und -1,3-diolverbindungen und deren verwendung zur behandlung von alzheimer-krankheit
TR200102009T2 (tr) Serebral işlemi profilaksı ve tedavisi için formül I'e göre bileşiklerin kullanımı
EP2266566A3 (de) Nicotinamid Derivate und ihrer Verwendung als Therapeutika
DE69619088D1 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
DE69908855D1 (de) 9a, 11b-dehydro Derivative von 9-oxime-3-keto-6-0-methylerythromycin
US6541495B1 (en) Carboxylic acid derivatives as inhibitors of hyperproliferation diseases

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee